Development of stabilized itraconazole nanodispersions by using high-gravity technique

Drug Development and Industrial Pharmacy

Volumn 38, Issue 12, 2012, Pages 1512-1520

  Zhang, Zhi Liang ^a   Le, Yuan ^a   Wang, Jie Xin ^a   Zhao, Hong ^a   Chen, Jian Feng ^a  

^a BEIJING UNIVERSITY OF CHEMICAL TECHNOLOGY   (China)

Author keywords

dissolution rate; Itrcanonzole; nanodispersions; poorly water soluble drug; rotating packed bed

Indexed keywords

HYDROXYPROPYLMETHYLCELLULOSE; ITRACONAZOLE; MANNITOL; NANOPARTICLE;

ARTICLE; CHEMICAL STRUCTURE; DIFFERENTIAL SCANNING CALORIMETRY; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; DRUG STRUCTURE; IN VITRO STUDY; INFRARED SPECTROSCOPY; PARTICLE SIZE; SCANNING ELECTRON MICROSCOPY; X RAY DIFFRACTION;

ANTIFUNGAL AGENTS; BIOLOGICAL AVAILABILITY; DRUG COMPOUNDING; DRUG STABILITY; GRAVITATION; ITRACONAZOLE; MICROSCOPY, ELECTRON, SCANNING; NANOPARTICLES; PARTICLE SIZE; SOLUBILITY; SPECTROSCOPY, FOURIER TRANSFORM INFRARED;

EID: 84868361446     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.3109/03639045.2012.654794     Document Type: Article

References (35)

1. Boogaerts MA, Maertens J, Van Der Geest R, Bosly A, Michaux JM, Van Hoof A et al. (2001). Pharmacokinetics and safety of a 7-day administration of intravenous itraconazole followed by a 14-day administration of itraconazole oral solution in patients with hematologic malignancy. Antimicrob Agents Chemother, 45:981-985. (Pubitemid 32182062)
2. DiNunzio JC, Miller DA, Yang W, McGinity JW, Williams RO 3rd. (2008). Amorphous compositions using concentration enhancing polymers for improved bioavailability of itraconazole. Mol Pharm, 5:968-980.
3. Barrett AM, Dehghani F, Foster NR. (2008). Increasing the dissolution rate of itraconazole processed by gas antisolvent techniques using polyethylene glycol as a carrier. Pharm Res, 25:1274-1289.
4. Sun W, Mao S, Shi Y, Li LC, Fang L. (2011). Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption. J Pharm Sci, 100:3365-3373.
5. Yang W, Johnston KP, Williams RO 3rd. (2010). Comparison of bioavailability of amorphous versus crystalline itraconazole nanoparticles via pulmonary administration in rats. Eur J Pharm Biopharm, 75:33-41.
6. Kim JK, Park JS, Kim CK. (2010). Development of a binary lipid nanoparticles formulation of itraconazole for parenteral administration and controlled release. Int J Pharm, 383:209-215.
7. Van Eerdenbrugh B, Vercruysse S, Martens JA, Vermant J, Froyen L, Van Humbeeck J et al. (2008). Microcrystalline cellulose, a useful alternative for sucrose as a matrix former during freeze-drying of drug nanosuspensions-a case study with itraconazole. Eur J Pharm Biopharm, 70:590-596.
8. Lee S, Nam K, Kim MS, Jun SW, Park JS, Woo JS et al. (2005). Preparation and characterization of solid dispersions of itraconazole by using aerosol solvent extraction system for improvement in drug solubility and bioavailability. Arch Pharm Res, 28:866-874. (Pubitemid 43080167)
9. Chingunpitak J, Puttipipatkhachorn S, Tozuka Y, Moribe K, Yamamoto K. (2008). Micronization of dihydroartemisinin by rapid expansion of supercritical solutions. Drug Dev Ind Pharm, 34:609-617. (Pubitemid 351878678)
10. Shanmugam S, Park JH, Chi SC, Yong CS, Choi HG, Woo JS. (2011). Physicochemical stability, pharmacokinetic, and biodistribution evaluation of paclitaxel solid dispersion prepared using supercritical antisolvent process. Drug Dev Ind Pharm, 37:628-637.
11. Vaughn JM, Gao X, Yacaman MJ, Johnston KP, Williams RO 3rd. (2005). Comparison of powder produced by evaporative precipitation into aqueous solution (EPAS) and spray freezing into liquid (SFL) technologies using novel Z-contrast STEM and complimentary techniques. Eur J Pharm Biopharm, 60:81-89. (Pubitemid 40545864)
12. Vaughn JM, McConville JT, Crisp MT, Johnston KP, Williams RO 3rd. (2006). Supersaturation produces high bioavailability of amorphous danazol particles formed by evaporative precipitation into aqueous solution and spray freezing into liquid technologies. Drug Dev Ind Pharm, 32:559-567.
13. Rogers TL, Nelsen AC, Sarkari M, Young TJ, Johnston KP, Williams RO 3rd. (2003). Enhanced aqueous dissolution of a poorly water soluble drug by novel particle engineering technology: sprayfreezing into liquid with atmospheric freeze-drying. Pharm Res, 20:485-493. (Pubitemid 36292193)
14. McConville JT, Overhoff KA, Sinswat P, Vaughn JM, Frei BL, Burgess DS et al. (2006). Targeted high lung concentrations of itraconazole using nebulized dispersions in a murine model. Pharm Res, 23:901-911. (Pubitemid 43781398)
15. Vaughn JM, McConville JT, Burgess D, Peters JI, Johnston KP, Talbert RL et al. (2006). Single dose and multiple dose studies of itraconazole nanoparticles. Eur J Pharm Biopharm, 63:95-102. (Pubitemid 43776206)
16. Matteucci ME, Brettmann BK, Rogers TL, Elder EJ, Williams RO 3rd, Johnston KP. (2007). Design of potent amorphous drug nanoparticles for rapid generation of highly supersaturated media. Mol Pharm, 4:782-793. (Pubitemid 350004278)
17. Kumar V, Wang L, Riebe M, Tung HH, Prud'homme RK. (2009). Formulation and stability of itraconazole and odanacatib nanoparticles: governing physical parameters. Mol Pharm, 6:1118-1124.
18. Matteucci ME, Hotze MA, Johnston KP, Williams RO 3rd. (2006). Drug nanoparticles by antisolvent precipitation: mixing energy versus surfactant stabilization. Langmuir, 22:8951-8959. (Pubitemid 44626160)
19. Rasenack N, Hartenhauer H, Müller BW. (2003). Microcrystals for dissolution rate enhancement of poorly water-soluble drugs. Int J Pharm, 254:137-145. (Pubitemid 36298822)
20. DiNunzio JC, Hughey JR, Brough C, Miller DA, Williams RO 3rd, McGinity JW. (2010). Production of advanced solid dispersions for enhanced bioavailability of itraconazole using KinetiSol Dispersing. Drug Dev Ind Pharm, 36:1064-1078.
21. Dontireddy R, Crean AM. (2011). A comparative study of spraydried and freeze-dried hydrocortisone/polyvinyl pyrrolidone solid dispersions. Drug Dev Ind Pharm, 37:1141-1149.
22. Zhang H, Wang D, Butler R, Campbell NL, Long J, Tan B et al. (2008). Formation and enhanced biocidal activity of water-dispersable organic nanoparticles. Nat Nanotechnol, 3:506-511.
23. Zhong J, Shen Z, Yang Y, Chen J. (2005). Preparation and characterization of uniform nanosized cephradine by combination of reactive precipitation and liquid anti-solvent precipitation under high gravity environment. Int J Pharm, 301:286-293. (Pubitemid 41206614)
24. Chen J, Wang Y, Guo F, Wang X, Zheng C. (2000). Synthesis of nanoparticles with novel technology: high-gravity reactive precipitation. Ind Eng Chem Res, 39:948-954. (Pubitemid 30210636)
25. Chen JF, Li YL, Wang YH, Yun J, Cao DP. (2004). Preparation and characterization of zinc sulfide nanoparticles under high-gravity environment. Mater Res Bull, 39:185-194.
26. Chen JF, Zhou MY, Shao L, Wang YY, Yun J, Chew NY et al. (2004). Feasibility of preparing nanodrugs by high-gravity reactive precipitation. Int J Pharm, 269:267-274. (Pubitemid 38032839)
27. Chen J, Zhang J, Shen Z, Zhong J, Yun J. (2006). Preparation and characterization of amorphous cefuroxime axetil drug nanoparticles with novel technology: high-gravity antisolvent precipitation. Ind Eng Chem Res, 45:8723-8727. (Pubitemid 46057423)
28. Sanganwar GP, Gupta RB. (2008). Enhancement of shelf life and handling properties of drug nanoparticles: nanoscale mixing of itraconazole with silica. Ind Eng Chem Res, 47:4717-4725.
29. Raghavan SL, Trividic A, Davis AF, Hadgraft J. (2001). Crystallization of hydrocortisone acetate: influence of polymers. Int J Pharm, 212:213-221. (Pubitemid 32119447)
30. Chaubal MV, Popescu C. (2008). Conversion of nanosuspensions into dry powders by spray drying: a case study. Pharm Res, 25:2302-2308.
31. Amidon G, Bergren M, Grant D, Marshall K, Itai S. (1999). Physical test methodsforpowderflowcharacterizationofpharmaceuticalmaterials: A review of methods. Pharmacopeial Forum, 35:8293-8308.
32. Meyer K, Zimmermann I. (2004). Effect of glidants in binary powder mixtures. Powder Technol, 139:40-54. (Pubitemid 38050138)
33. Jonat S, Hasenzahl S, Drechsler M, Albers P, Wagner KG, Schmidt PC. (2004). Investigation of compacted hydrophilic and hydrophobic colloidal silicon dioxides as glidants for pharmaceutical excipients. Powder Technol, 141:31-43. (Pubitemid 38569826)
34. Zhao H, Wang J, Wang Q, Chen J, Yun J. (2007). Controlled liquid antisolvent precipitation of hydrophobic pharmaceutical nanoparticles in a microchannel reactor. Ind Eng Chem Res, 46:8229-8235. (Pubitemid 350208033)
35. Le Y, Ji H, Chen JF, Shen Z, Yun J, Pu M. (2009). Nanosized bicalutamide and its molecular structure in solvents. Int J Pharm, 370:175-180.